Eli Lilly Stock (LLY) After Hours Drops on Wegovy Pill Approval: What to Know Before the Market Opens Dec. 23, 2025
Eli Lilly and Company (NYSE: LLY) ended Monday’s regular session higher — then slipped after the closing bell as investors digested a major late-day headline from its biggest obesity rival, Novo Nordisk. LLY closed at $1,076.48 (+0.47%) at 4:00 p.m.